Bridging anticoagulation therapy with low molecular weight heparin in patients with atrial fibrillation following a stroke is associated with adverse events
- PMID: 31772062
- DOI: 10.1136/ebnurs-2019-103190
Bridging anticoagulation therapy with low molecular weight heparin in patients with atrial fibrillation following a stroke is associated with adverse events
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Anticoagulation After Stroke in Patients With Atrial Fibrillation.Stroke. 2019 Aug;50(8):2093-2100. doi: 10.1161/STROKEAHA.118.022856. Epub 2019 Jun 21. Stroke. 2019. PMID: 31221054
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical